Optomed PLC
Optomed Oyj, together with its subsidiaries, manufactures and sells handheld fundus cameras in Finland, rest of Europe, and internationally. The company operates in two segments, Devices and Software. It develops, manufactures, and sells fundus cameras for ophthalmologists, pediatricians, endocrinologists, neurologists, and primary health care professionals; and provides professional IT consultin… Read more
Optomed PLC (OPTOMED) - Net Assets
Latest net assets as of September 2025: €20.24 Million EUR
Based on the latest financial reports, Optomed PLC (OPTOMED) has net assets worth €20.24 Million EUR as of September 2025.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (€27.19 Million) and total liabilities (€6.95 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | €20.24 Million |
| % of Total Assets | 74.45% |
| Annual Growth Rate | 22.7% |
| 5-Year Change | 17.76% |
| 10-Year Change | N/A |
| Growth Volatility | 148.99 |
Optomed PLC - Net Assets Trend (2015–2024)
This chart illustrates how Optomed PLC's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Optomed PLC (2015–2024)
The table below shows the annual net assets of Optomed PLC from 2015 to 2024.
| Year | Net Assets | Change |
|---|---|---|
| 2024-12-31 | €23.64 Million | +16.09% |
| 2023-12-31 | €20.36 Million | +0.09% |
| 2022-12-31 | €20.34 Million | +19.29% |
| 2021-12-31 | €17.05 Million | -15.05% |
| 2020-12-31 | €20.07 Million | -11.33% |
| 2019-12-31 | €22.64 Million | +307.69% |
| 2018-12-31 | €5.55 Million | +377.47% |
| 2017-12-31 | €1.16 Million | -66.99% |
| 2016-12-31 | €3.52 Million | -6.00% |
| 2015-12-31 | €3.75 Million | -- |
Equity Component Analysis
This analysis shows how different components contribute to Optomed PLC's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 2867600000.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (December 2024)
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | €80.00K | 0.34% |
| Other Comprehensive Income | €59.61 Million | 252.21% |
| Other Components | €504.00K | 2.13% |
| Total Equity | €23.64 Million | 100.00% |
Optomed PLC Competitors by Market Cap
The table below lists competitors of Optomed PLC ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Jetpak Top Holding AB
ST:JETPAK
|
$35.56 Million |
|
BIOMED-LUBLIN WYT.SUR.
F:6NQ
|
$35.57 Million |
|
BANGO PLC LS-20
F:B1O
|
$35.58 Million |
|
Nyrada Inc
AU:NYR
|
$35.58 Million |
|
Lisata Therapeutics Inc.
NASDAQ:LSTA
|
$35.53 Million |
|
Orient Technologies Limited
NSE:ORIENTTECH
|
$35.51 Million |
|
Sea Forest Limited
AU:SEA
|
$35.50 Million |
|
SeA Mechanics Co. Ltd.
KQ:396300
|
$35.50 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Optomed PLC's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from 20,361,000 to 23,637,000, a change of 3,276,000 (16.1%).
- Net loss of 5,450,000 reduced equity.
- Share repurchases of 9,182,000 reduced equity.
- Other comprehensive income increased equity by 8,344,001.
- Other factors increased equity by 9,563,999.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | €-5.45 Million | -23.06% |
| Share Repurchases | €9.18 Million | -38.85% |
| Other Comprehensive Income | €8.34 Million | +35.3% |
| Other Changes | €9.56 Million | +40.46% |
| Total Change | €- | 16.09% |
Book Value vs Market Value Analysis
This analysis compares Optomed PLC's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 1.88x
- The company is trading above its book value, indicating the market recognizes value beyond its reported assets.
- The price-to-book ratio has decreased from 8.91x to 1.88x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2016-12-31 | €0.27 | €2.38 | x |
| 2017-12-31 | €0.09 | €2.38 | x |
| 2018-12-31 | €0.42 | €2.38 | x |
| 2019-12-31 | €2.53 | €2.38 | x |
| 2020-12-31 | €1.51 | €2.38 | x |
| 2021-12-31 | €1.27 | €2.38 | x |
| 2022-12-31 | €1.39 | €2.38 | x |
| 2023-12-31 | €1.22 | €2.38 | x |
| 2024-12-31 | €1.27 | €2.38 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Optomed PLC utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): -23.06%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -36.24%
- • Asset Turnover: 0.47x
- • Equity Multiplier: 1.34x
- Recent ROE (-23.06%) is above the historical average (-52.73%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2016 | -78.29% | -41.73% | 0.66x | 2.85x | €-3.11 Million |
| 2017 | -248.24% | -41.85% | 0.70x | 8.53x | €-3.00 Million |
| 2018 | -22.83% | -8.77% | 0.68x | 3.81x | €-1.82 Million |
| 2019 | -12.70% | -19.20% | 0.38x | 1.75x | €-5.14 Million |
| 2020 | -15.83% | -24.42% | 0.42x | 1.55x | €-5.18 Million |
| 2021 | -24.92% | -28.61% | 0.51x | 1.70x | €-5.95 Million |
| 2022 | -26.90% | -37.33% | 0.47x | 1.54x | €-7.51 Million |
| 2023 | -21.81% | -29.41% | 0.52x | 1.43x | €-6.48 Million |
| 2024 | -23.06% | -36.24% | 0.47x | 1.34x | €-7.81 Million |
Industry Comparison
This section compares Optomed PLC's net assets metrics with peer companies in the Health Information Services industry.
Industry Context
- Industry: Health Information Services
- Average net assets among peers: $66,166,000
- Average return on equity (ROE) among peers: -27.90%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Optomed PLC (OPTOMED) | €20.24 Million | -78.29% | 0.34x | $35.53 Million |
| Nightingale Health Oyj B (HEALTH) | $66.17 Million | -27.90% | 0.13x | $50.54 Million |